Drug Trial Radar · NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
900
Planned (sponsor's estimate)
Start
Jul 6, 2026
Primary completion
Jul 13, 2028
Study completion Jul 13, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin 10 mg as per guideline directed medical therapy (GDMT) for chronic kidney disease (CKD). Additionally, participants are on other glucose-lowering medication(s).
Conditions
- Type 2 Diabetes Mellitus
- Type 2 Diabetes With Chronic Kidney Disease
Interventions
ElecoglipronDrug
Elecoglipron is administered orally once daily.
PlaceboDrug
Placebo is administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline to Week 40
Locations
186 sites in 16 countries. Site status is shown where the registry gives one.
Research Site
Sun City, Arizona · Not yet recruiting
Research Site
Surprise, Arizona · Not yet recruiting
Research Site
Concord, California · Not yet recruiting
Research Site
Sacramento, California · Recruiting
Research Site
Victorville, California · Not yet recruiting
Research Site
Fleming Island, Florida · Not yet recruiting
Research Site
Lauderdale Lakes, Florida · Not yet recruiting
Research Site
Leesburg, Florida · Not yet recruiting
Research Site
Miami Lakes, Florida · Recruiting
Research Site
Ocoee, Florida · Recruiting
Research Site
Orlando, Florida · Not yet recruiting
Research Site
Chicago, Illinois · Not yet recruiting
Research Site
Braintree, Massachusetts · Not yet recruiting
Research Site
New Bedford, Massachusetts · Not yet recruiting
Research Site
Worcester, Massachusetts · Not yet recruiting
Research Site
Saint Joseph, Michigan · Suspended
Research Site
Saint Paul, Minnesota · Not yet recruiting
Research Site
Kansas City, Missouri · Recruiting
Research Site
Omaha, Nebraska · Not yet recruiting
Research Site
Las Vegas, Nevada · Not yet recruiting
Research Site
Albuquerque, New Mexico · Recruiting
Research Site
The Bronx, New York · Not yet recruiting
Research Site
Kinston, North Carolina · Not yet recruiting
Research Site
Raleigh, North Carolina · Recruiting
Research Site
Winston-Salem, North Carolina · Not yet recruiting
Research Site
Cincinnati, Ohio · Not yet recruiting
Research Site
East Providence, Rhode Island · Not yet recruiting
Research Site
Gaffney, South Carolina · Recruiting
Research Site
Greenville, South Carolina · Not yet recruiting
Research Site
San Antonio, Texas · Suspended
Research Site
San Antonio, Texas · Not yet recruiting
Research Site
Ogden, Utah · Not yet recruiting
Research Site
Arlington, Virginia · Suspended
Research Site
Dupnitsa, Bulgaria · Not yet recruiting
Research Site
Haskovo, Bulgaria · Not yet recruiting
Research Site
Kyustendil, Bulgaria · Not yet recruiting
Research Site
Pleven, Bulgaria · Not yet recruiting
Research Site
Plovdiv, Bulgaria · Not yet recruiting
Research Site
Rousse, Bulgaria · Not yet recruiting
Research Site
Stara Zagora, Bulgaria · Not yet recruiting
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.